← Eichor
Study identifier: NCT06599372 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia

Condition: Schizophrenia · Transcranial Magnetic Stimulation · Hallucinations, Verbal Auditory  ·  Sponsor: Dominique JANUEL

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This open naturalistic study aims to evaluate the efficacy of rTMS in routine practice on auditory resistant hallucinations (AHR) of patients with schizophrenia. To this end, two stimulation methods will be offered to patients: the rTMS stimulation method and the cTBS stimulation method.We principally use the AHRS scale to evaluate the effectiveness of rTMS on RAH in patients with schizophrenia. Our main hypothesis is that rTMS used under naturalistic conditions, in addition to antipsychotics, would allow a relative improvement of resistant auditory hallucinations assessed by the AHRS scale between baseline and end of treatment in patients with schizophrenia.

This description comes directly from the study's public registry record.

Talk to the study team

Youcef Bencherif  ·  +33 1 43 09 32 32  ·  urcve1@gmail.com

Rusheentira Thavaseelan  ·  +33 1 43 09 32 32  ·  urcve1@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Etablissement Public de Santé de Ville-EvrardNeuilly-sur-Marne, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06599372